Jpmorgan Chase & Co »

Artiva Biotherapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 4.0k 2.87
2025-03-31 $54k 18k 3.00
2024-12-31 $379k 38k 10.08
2024-09-30 $166k 11k 15.45